Cancer Australia has executed a contract with the University of Technology, as represented by the Centre for Health Economics Research and Evaluation (CHERE) as the supplier for the Health- and Pharmaco-economics (HE) National Technical Service (NTS). CHERE will provide Multi-site Collaborative Cancer Clinical Trials Groups with expert advice and support for the inclusion of HE measures/sub-studies into investigator-initiated and industry-independent cancer clinical trial concepts and protocols for the period 1 July 2025 to 30 June 2027.

This is the latest observation of this contract, and the explorer’s totals use its value.

$656,733.00

Full reported contract value · AUD including applicable GST · 2025-07-01 to 2027-06-30

Reporting agency: Cancer Australia
Reported supplier: University of Technology Sydney
Reported ABN: 77 257 686 961. Exemption as supplied: No.
Category: Health administration services
Procurement method: Open tender
Original publication: 2025-07-03 16:23:00 (ACT local time as supplied)
Amendment publication: Original notice; no amendment publication supplied
Amendment reason: Not supplied
Agency reference: PO1413
Approach to market / standing offer: HE NTS 24/202 / Standing offer not supplied
Consultancy: No
Confidentiality as reported: Contract: No; outputs: No
Source observation: CN4165876 · Official weekly workbook ending 2025-07-05 · sheet “Contract Notice Export”, row 2541.

The original register may now show later corrections. The card and this observation keep the saved source date.